Ignite Creation Date:
2024-05-06 @ 7:26 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06018337
Status:
RECRUITING
Last Update Posted:
2024-06-06
First Post:
2023-08-25
Brief Title:
A Study of DB-1303BNT323 vs Investigators Choice Chemotherapy in HER2-Low Hormone Receptor Positive Metastatic Breast Cancer DYNASTY-Breast02
Sponsor:
DualityBio Inc
Organization:
DualityBio Inc